Unlisted pharmas receive excellent sales report card

Unlisted pharmaceutical companies, most of them are relying on selling generic products, were observed to receive an excellent report card for their business last year.

Their sales were increased by more than 10% and had profitability with fairly decent operating profits, but the gap between the rich and poor was intensified.

According to the Yakup Shinmoon’s(www.yakup.com) analysis result of...